Extensive studies have established that elevated levels of both TILs and PD-L1 expression correlate with a favorable prognosis in cancers(e.g., breast cancer), and with the efficacy of neoadjuvant chemotherapy (11, 49, 50). Here, CD274 is linked to breast carcinoma.